RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The influence of perceived dapivirine vaginal ring effectiveness on social disclosure and ring adherence
Stoner, M. C. D., Brown, E. R., Palanee-Phillips, T., Mansoor, L. E., Tembo, T., Nair, G., Akello, C., Seyama, L., Jeenarain, N., Naidoo, L., Mgodi, N., Hunidzarira, P., Chitukuta, M., van der Straten, A., & MTN-020 ASPIRE and M-025 HOPE study teams (2021). The influence of perceived dapivirine vaginal ring effectiveness on social disclosure and ring adherence. AIDS and Behavior, 25(12), 4169-4179. https://doi.org/10.1007/s10461-021-03286-w
We analyzed data from 1428 users of the dapivirine vaginal ring, who participated in the MTN-020/ASPIRE phase III trial and subsequent open-label extension MTN-025/HOPE trial, to examine relationships between perceived ring protection, social disclosures, and self-reported ring adherence. In HOPE, 77% perceived the ring to be highly effective, and this view was associated with speaking: (a) to a greater number of people about the study, (b) with other participants, (c) to more people who were in favor of the ring, and (d) to more people whose opinions were valued. Reported adherence was not directly associated with perceived protection but was associated with disclosing to someone who was in favor of the ring. These findings suggest the importance of women's internalized ideas about the protective benefits of the DVR in sharing information about the ring and the importance of social support on adherence.
